Dendrimer-based RNA interference delivery for cancer therapy

Leyuan Xu; W. Andrew Yeudall; Hu Yang

doi:10.1021/bk-2013-1135.ch012

Dendrimer-based RNA interference delivery for cancer therapy

Leyuan Xu, W. Andrew Yeudall, Hu Yang

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

12 Scopus citations

Abstract

RNA interference (RNAi) has emerged as a promising tool for cancer treatment. A strenuous ongoing effort for translation of RNAi into clinically acceptable therapy is the development of vectors for efficient and targeted RNAi delivery. In this chapter, we review RNAi-based cancer treatment and the utility of dendrimers in RNAi delivery.

Original language	English (US)
Title of host publication	Tailored Polymer Architectures for Pharmaceutical and Biomedical Applications
Publisher	American Chemical Society
Pages	197-213
Number of pages	17
ISBN (Print)	9780841227989
DOIs	https://doi.org/10.1021/bk-2013-1135.ch012
State	Published - Jul 8 2013
Externally published	Yes

Publication series

Name	ACS Symposium Series
Volume	1135
ISSN (Print)	0097-6156
ISSN (Electronic)	1947-5918

ASJC Scopus subject areas

General Chemistry
General Chemical Engineering

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1021/bk-2013-1135.ch012

Cite this

@inproceedings{8eb87d8913874d1596171fd68cf0df6d,

title = "Dendrimer-based RNA interference delivery for cancer therapy",

abstract = "RNA interference (RNAi) has emerged as a promising tool for cancer treatment. A strenuous ongoing effort for translation of RNAi into clinically acceptable therapy is the development of vectors for efficient and targeted RNAi delivery. In this chapter, we review RNAi-based cancer treatment and the utility of dendrimers in RNAi delivery.",

author = "Leyuan Xu and {Andrew Yeudall}, W. and Hu Yang",

year = "2013",

month = jul,

day = "8",

doi = "10.1021/bk-2013-1135.ch012",

language = "English (US)",

isbn = "9780841227989",

series = "ACS Symposium Series",

publisher = "American Chemical Society",

pages = "197--213",

booktitle = "Tailored Polymer Architectures for Pharmaceutical and Biomedical Applications",

}

TY - GEN

T1 - Dendrimer-based RNA interference delivery for cancer therapy

AU - Xu, Leyuan

AU - Andrew Yeudall, W.

AU - Yang, Hu

PY - 2013/7/8

Y1 - 2013/7/8

N2 - RNA interference (RNAi) has emerged as a promising tool for cancer treatment. A strenuous ongoing effort for translation of RNAi into clinically acceptable therapy is the development of vectors for efficient and targeted RNAi delivery. In this chapter, we review RNAi-based cancer treatment and the utility of dendrimers in RNAi delivery.

AB - RNA interference (RNAi) has emerged as a promising tool for cancer treatment. A strenuous ongoing effort for translation of RNAi into clinically acceptable therapy is the development of vectors for efficient and targeted RNAi delivery. In this chapter, we review RNAi-based cancer treatment and the utility of dendrimers in RNAi delivery.

UR - http://www.scopus.com/inward/record.url?scp=84905397389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905397389&partnerID=8YFLogxK

U2 - 10.1021/bk-2013-1135.ch012

DO - 10.1021/bk-2013-1135.ch012

M3 - Conference contribution

AN - SCOPUS:84905397389

SN - 9780841227989

T3 - ACS Symposium Series

SP - 197

EP - 213

BT - Tailored Polymer Architectures for Pharmaceutical and Biomedical Applications

PB - American Chemical Society

ER -

Dendrimer-based RNA interference delivery for cancer therapy

Abstract

Publication series

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this